Patented Drug Extension Strategies on Healthcare Spending: A Cost-Evaluation Analysis

Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades

(2013) Tahir Amin et al.   HEALTH AFFAIRS

Making medicines evergreen

(2012) A. W. Hitchings et al.   BMJ-British Medical Journal

Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder

(2011) Eric Q Wu et al.   ANNALS OF PHARMACOTHERAPY

Why Do the Same Drugs Look Different? Pills, Trade Dress, and Public Health

(2011) Jeremy A. Greene et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does the Market Share of Generic Medicines Influence the Price Level?

(2011) Pieter Dylst et al.   PHARMACOECONOMICS

Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests

(2010) R. Achermann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Impact of pharmaceutical representative visits on GPs' drug preferences

(2009) J. Sondergaard et al.   FAMILY PRACTICE

The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland

(2009) Johanna Timonen et al.   HEALTH POLICY

Lessons from 60 years of pharmaceutical innovation

(2009) Bernard Munos   NATURE REVIEWS DRUG DISCOVERY

Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use

(2009) S. Swaroop Vedula et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Neurontin Legacy — Marketing through Misinformation and Manipulation

(2009) C. Seth Landefeld et al.   NEW ENGLAND JOURNAL OF MEDICINE